Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape; Cancers; Vol. 12, iss. 10
| Parent link: | Cancers Vol. 12, iss. 10.— 2020.— [3014, 15 p.] |
|---|---|
| Korporativna značnica: | Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий Научно-исследовательский центр "Онкотераностика" |
| Drugi avtorji: | Shramova E. I. Elena Ivanovna, Proshkina G. M. Galina Mikhaylovna, Shipunova V. Viktoriya, Ryabova A. Anastasiya, Kamyshinsky R. Roman, Konevega A. Andrey, Shulga (Schulga) A. A. Aleksey Anatolievich, Konovalova E. V. Elena Valerjevna, Telegin G. Georgy, Deev S. M. Sergey Mikhaylovich |
| Izvleček: | Title screen We report here a combined anti-cancer therapy directed toward HER2 and EpCAM, common tumor-associated antigens of breast cancer cells. The combined therapeutic effect is achieved owing to two highly toxic proteins—a low immunogenic variant of Pseudomonas aeruginosa exotoxin A and ribonuclease Barnase from Bacillus amyloliquefaciens. The delivery of toxins to cancer cells was carried out by targeting designed ankyrin repeat proteins (DARPins). We have shown that both target agents efficiently accumulate in the tumor. Simultaneous treatment of breast carcinoma-bearing mice with anti-EpCAM fusion toxin based on LoPE and HER2-specific liposomes loaded with Barnase leads to concurrent elimination of primary tumor and metastases. Monotherapy with anti-HER2- or anti-EpCAM-toxins did not produce a comparable effect on metastases. The proposed approach can be considered as a promising strategy for significant improvement of cancer therapy. |
| Jezik: | angleščina |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://doi.org/10.3390/cancers12103014 |
| Format: | Elektronski Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664919 |
Podobne knjige/članki
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1; International Journal of Molecular Sciences; Vol. 21, iss. 9
Izdano: (2020)
Izdano: (2020)
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1; Molecules; Vol. 25, iss. 20
Izdano: (2020)
Izdano: (2020)
Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1; International Journal of Biological Macromolecules; Vol. 145
Izdano: (2020)
Izdano: (2020)
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1; Molecular Pharmaceutics; Vol. 23, iss. 4
Izdano: (2026)
Izdano: (2026)
Cancer-Targeted Drug Delivery
Izdano: (2025)
Izdano: (2025)
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin; Pharmaceutics; Vol. 11, iss. 5
Izdano: (2019)
Izdano: (2019)
HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model; International Journal of Molecular Sciences; Vol. 20, iss. 10
Izdano: (2019)
Izdano: (2019)
Handbook of Cancer and Immunology
Izdano: (2022)
Izdano: (2022)
Cancer Vaccines Methods and Protocols /
Izdano: (2025)
Izdano: (2025)
Влияние расположения ABD на таргетные свойства нового бивалентного терапевтического конъюгата на основе DARPin G3; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
od: Прач А. А. Анастасия Александровна
Izdano: (2024)
od: Прач А. А. Анастасия Александровна
Izdano: (2024)
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs; Journal of Controlled Release; Vol. 355
Izdano: (2023)
Izdano: (2023)
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
Izdano: (2021)
Izdano: (2021)
Optimal Impulsive Control for Cancer Therapy
od: Belfo, João P., et al.
Izdano: (2021)
od: Belfo, João P., et al.
Izdano: (2021)
Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model; Pharmaceutics; Vol. 12, iss. 6
Izdano: (2020)
Izdano: (2020)
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab; Cancers; Vol. 15 - iss. 9
Izdano: (2023)
Izdano: (2023)
Cancer Bioinformatics
Izdano: (2019)
Izdano: (2019)
Ovarian Cancer Methods and Protocols /
Izdano: (2022)
Izdano: (2022)
Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer; Physica Medica; Vol. 73
Izdano: (2020)
Izdano: (2020)
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4
Izdano: (2024)
Izdano: (2024)
Metal-Organic Frameworks (MOFs) for Cancer Therapy; Materials; Vol. 14, iss. 23
Izdano: (2021)
Izdano: (2021)
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer; EJNMMI Research; Vol. 10, iss. 1
Izdano: (2020)
Izdano: (2020)
Cancer Cytogenetics Methods and Protocols /
Izdano: (2017)
Izdano: (2017)
Cancer Epigenetics Methods and Protocols /
Izdano: (2012)
Izdano: (2012)
Prostate Cancer Methods and Protocols /
Izdano: (2018)
Izdano: (2018)
Proteases and Cancer Methods and Protocols /
Izdano: (2018)
Izdano: (2018)
Inflammation and Cancer Methods and Protocols /
Izdano: (2018)
Izdano: (2018)
Cancer Nanotechnology Methods and Protocols /
Izdano: (2017)
Izdano: (2017)
Lung Cancer Methods and Protocols /
Izdano: (2021)
Izdano: (2021)
Cancer Immunosurveillance Methods and Protocols /
Izdano: (2019)
Izdano: (2019)
Pancreatic Cancer Methods and Protocols /
Izdano: (2019)
Izdano: (2019)
Cancer Metabolism Methods and Protocols /
Izdano: (2019)
Izdano: (2019)
Autophagy and Cancer Methods and Protocols /
Izdano: (2022)
Izdano: (2022)
Podobne knjige/članki
-
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1; International Journal of Molecular Sciences; Vol. 21, iss. 9
Izdano: (2020) -
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1; Molecules; Vol. 25, iss. 20
Izdano: (2020) -
Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1; International Journal of Biological Macromolecules; Vol. 145
Izdano: (2020) -
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1; Molecular Pharmaceutics; Vol. 23, iss. 4
Izdano: (2026) -
Cancer-Targeted Drug Delivery
Izdano: (2025)